Implementation of pharmacogenomics: Where are we now?

S Medwid, RB Kim - British Journal of Clinical Pharmacology, 2024 - Wiley Online Library
Pharmacogenomics (PGx), examining the effect of genetic variation on interpatient variation
in drug disposition and response, has been widely studied for several decades. However, as …

[HTML][HTML] Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review

L Ahmed, A Constantinidou, A Chatzittofis - Frontiers in Medicine, 2023 - frontiersin.org
Background Precision medicine is growing due to technological advancements including
next generation sequencing techniques and artificial intelligence. However, with the …

Integrating pharmacogenomic testing into personalized medicine practices in the USA: Implications for medication quality control and therapeutic efficacy

JT Bature, MA Eruaga, EO Itua - GSC Biological and …, 2024 - gsconlinepress.com
This concept paper explores the integration of pharmacogenomic testing into personalized
medicine practices in the USA and its implications for medication quality control and …

[HTML][HTML] A blockchain-based framework to support pharmacogenetic data sharing

F Albalwy, JH McDermott, WG Newman… - The …, 2022 - nature.com
The successful implementation of pharmacogenetics (PGx) into clinical practice requires
patient genomic data to be shared between stakeholders in multiple settings. This creates a …

Integrating China in the international consortium for personalized medicine: A position paper on personalized medicine in sustainable healthcare

FA Causio, F Beccia, I Hoxhaj, HY Huang… - Public Health …, 2024 - karger.com
Introduction: Over the last decade, the emergence and spread of personalized medicine
(PM) have defined a substantial revolution in healthcare. In principle, healthcare system …

[HTML][HTML] Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals' education and citizens' …

F Beccia, FA Causio, I Hoxhaj, HY Huang, L Wang… - BMC Medical …, 2023 - Springer
Background Personalised medicine (PM) has been fostered by technological and medical
advances, but all stakeholders, including healthcare professionals, citizens and policy …

[HTML][HTML] The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature

A Alzoubi, H Shirazi, A Alrawashdeh, AM Al-Dekah… - Pharmaceutics, 2024 - mdpi.com
Precision oncology and pharmacogenomics (PGx) intersect in their overarching goal to
institute the right treatment for the right patient. However, the translation of these innovations …

[HTML][HTML] Optimizing Retail Pharmacy Success: The Role of Multichannel Marketing Strategies

A Wick, B Koczian, K Králiková - Administrative Sciences, 2024 - mdpi.com
This study focuses on the effect of multichannel marketing communication in retail
pharmacies to establish customer satisfaction in a world experiencing the digitalization of …

[HTML][HTML] Moving towards the implementation of pharmacogenetic testing in Quebec

LJ Li, S Legeay, AL Gagnon, MP Frigon… - Frontiers in …, 2024 - frontiersin.org
Clinical implementation of pharmacogenetics (PGx) into routine care will elevate the current
paradigm of treatment decisions. However, while PGx tests are increasingly becoming …

Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study

A Cernat, Z Samaan, J Abelson, A Ramdyal… - Journal of Community …, 2024 - Springer
Many patients with major depressive disorder (MDD) try multiple antidepressants before
finding one that works well and is tolerable. Pharmacogenomic (PGx) testing was developed …